Citation 71765

LUO,SQ: LIN,LZ: CORDELL,GA: XUE,L: JOHNSON,ME:. (1993). POLYOXYPREGNANES FROM MARSDENIA TENACISSIMA.. 34(6)

Citation Details

Title	POLYOXYPREGNANES FROM MARSDENIA TENACISSIMA.
Authors	LUO,SQ: LIN,LZ: CORDELL,GA: XUE,L: JOHNSON,ME:
Year	1993
Volume	34
Issue	6

Summary

Year: 1993

Journal: Unknown

Organisms and Their Experiments (1)

Marsdenia tenacissima (ASCLEPIADACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TENACIGENIN B,11-ALPHA-O-TIGLOYL-12-BETA-O-ACETYL:	None
2	ANTIINFLAMMATORY ACTIVITY	MEDICINAL FOLKLORE REPORTED FOR	None	None
3	ANTITUMOR ACTIVITY	MEDICINAL FOLKLORE REPORTED FORANTICANCER AND/OR CYTOTOXICITY MARKER CODE	None	None
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-TIGLOYL-12-BETA-O-ACETYL:	INACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-TIGLOYL-12-BETA-O-ACETYL:	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-TIGLOYL-12-BETA-O-ACETYL:	INACTIVE
7	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TENACIGENIN B,11-ALPHA-O-BENZOYL-12-BETA-O-ACETYL:	None
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-BENZOYL-12-BETA-O-ACETYL:	INACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-BENZOYL-12-BETA-O-ACETYL:	INACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-BENZOYL-12-BETA-O-ACETYL:	INACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-ACETYL:	None
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-ACETYL:	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-ACETYL:	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-ACETYL:	INACTIVE
15	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-TIGLOYL:	None
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-TIGLOYL:	INACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-TIGLOYL:	INACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-TIGLOYL:	ACTIVE
19	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-BENZOYL:	None
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-BENZOYL:	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-BENZOYL:	INACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,11-ALPHA-O-2-METHYL-BUTYRYL-12-BETA-O-BENZOYL:	INACTIVE
23	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	TENACIGENIN B,17-BETA: 11-ALPHA-12-BETA-O-DITIGLOYL:	None
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,17-BETA: 11-ALPHA-12-BETA-O-DITIGLOYL:	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,17-BETA: 11-ALPHA-12-BETA-O-DITIGLOYL:	INACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	TENACIGENIN B,17-BETA: 11-ALPHA-12-BETA-O-DITIGLOYL:	INACTIVE

Citation 71765

Citation Details

Summary

Organisms and Their Experiments (1)

Marsdenia tenacissima (ASCLEPIADACEAE)

Show SPARQL Queries (1)

Query 1